Drug Safety

Fraudulent and Substandard Medicines: Getting Away with Murder?
pp. 445-448(4)
Author: Edwards, I. Ralph

A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery
pp. 449-463(15)
Authors: Schulman, Sam; Majeed, Ammar

Quinolones: Review of Psychiatric and Neurological Adverse Reactions
pp. 465-488(24)
Authors: Tomé, Ana M.; Filipe, Augusto

Impact of a Pharmacotherapeutic Programme on Control and Safety of Long-Term Anticoagulation Treatment: A Controlled Follow-Up Study in Spain
pp. 489-500(12)
Authors: Duran-Parrondo, Carmen; Vazquez-Lago, Juan M.; Campos-Lopez, Ana M.; Figueiras, Adolfo

Risk of Depressive Episodes with Rimonabant: A Before and After Modified Prescription Event Monitoring Study Conducted in England
pp. 501-509(9)
Authors: Buggy, Yvonne; Cornelius, Victoria; Wilton, Lynda; Shakir, Saad A.W.

Prescription Patterns in Asthma Patients Initiating Salmeterol in UK General Practice: A Retrospective Cohort Study using the General Practice Research Database (GPRD)
pp. 511-520(10)
Authors: DiSantostefano, Rachael L.; Davis, Kourtney J.

Fatal Toxicity from Symptomatic Hyperlactataemia: A Retrospective Cohort Study of Factors Implicated with Long-Term Nucleoside Reverse Transcriptase Inhibitor use in a South African Hospital
pp. 521-527(7)
Authors: Leung, Liza; Wilson, Douglas; Manini, Alex F.

The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development
pp. 529-530(2)
Authors: Callréus, Torbjörn

The Authors' Reply
pp. 530-531(2)
Authors: Borg, John-Joseph; Aislaitner, George; Pirozynski, Michal; Mifsud, Stephen